Gsa Capital Partners LLP Sera Prognostics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.2 Billion
- Q3 2025
A detailed history of Gsa Capital Partners LLP transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 65,190 shares of SERA stock, worth $192,962. This represents 0.02% of its overall portfolio holdings.
Number of Shares
65,190
Previous 62,534
4.25%
Holding current value
$192,962
Previous $173,000
15.03%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SERA
# of Institutions
64Shares Held
21.9MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY5.5MShares$16.3 Million0.14% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.63MShares$10.8 Million3.75% of portfolio
-
Interwest Venture Management CO2.42MShares$7.15 Million21.78% of portfolio
-
Abrdn PLC2.28MShares$6.75 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$4.89 Million0.8% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $87.6M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...